Offstream
news

A study shows that the vaccine developed by Moderna is effective against SARS-CoV-2 variants including the Lineage B.1.617 Delta variant.
2021-06-29

The United States sends 2.5 million doses of Moderna’s vaccine to Taiwan.
2021-06-20

The United States government purchases 200 million doses of the vaccine produced by Moderna.
2021-06-16

Moderna says that it has requested full approval for its vaccine from the U.S. Food and Drug Administration. Currently, it has only been approved for emergency use.
2021-06-1

The government signs an agreement with Moderna to purchase 25 million doses of its vaccine.
2021-05-13

Moderna says its vaccine is 90% effective against COVID-19, and 95% effective against severe disease for six months after the second dose. It also says its vaccine is effective against the 501.V2 variant from South Africa.
2021-04-13

Moderna begins testing its vaccine in babies and children aged six months to 11 years in the U.S. and Canada.
2021-03-16

The Medicines and Healthcare products Regulatory Agency approves a vaccine made by Moderna for use in the UK. This comes after clinical trials found the vaccine had an efficacy of 94.1% and 100% for severe cases.
2021-01-8

United States Forces Korea begins a vaccination programme against COVID-19 using the Moderna vaccine. Healthcare providers and first responders are among those who will initially receive the vaccine.
2020-12-29

Health Canada approves the Moderna vaccine and expects that up to 168,000 doses will arrive in Canada by the end of the year.
2020-12-23